Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Br J Dermatol ; 179(4): 951-958, 2018 10.
Artículo en Inglés | MEDLINE | ID: mdl-29729180

RESUMEN

BACKGROUND: Carriage rates of Staphylococcus aureus on affected skin in atopic dermatitis (AD) are approximately 70%. Increasing disease severity during flares and overall disease severity correlate with increased burden of S. aureus. Treatment in AD therefore often targets S. aureus with topical and systemic antimicrobials. OBJECTIVES: To determine whether antimicrobial sensitivities and genetic determinants of resistance differed in S. aureus isolates from the skin of children with AD and healthy child nasal carriers. METHODS: In this case-control study, we compared S. aureus isolates from children with AD (n = 50) attending a hospital dermatology department against nasal carriage isolates from children without skin disease (n = 49) attending a hospital emergency department for noninfective conditions. Using whole genome sequencing we generated a phylogenetic framework for the isolates based on variation in the core genome, then compared antimicrobial resistance phenotypes and genotypes between disease groups. RESULTS: Staphylococcus aureus from cases and controls had on average similar numbers of phenotypic resistances per isolate. Case isolates differed in their resistance patterns, with fusidic acid resistance (FusR ) being significantly more frequent in AD (P = 0·009). The genetic basis of FusR also differentiated the populations, with chromosomal mutations in fusA predominating in AD (P = 0·049). Analysis revealed that FusR evolved multiple times and via multiple mechanism in the population. Carriage of plasmid-derived qac genes, which have been associated with reduced susceptibility to antiseptics, was eight times more frequent in AD (P = 0·016). CONCLUSIONS: The results suggest that strong selective pressure drives the emergence and maintenance of specific resistances in AD.


Asunto(s)
Antiinfecciosos Locales/efectos adversos , Dermatitis Atópica/microbiología , Farmacorresistencia Bacteriana/efectos de los fármacos , Infecciones Cutáneas Estafilocócicas/microbiología , Staphylococcus aureus/fisiología , Administración Cutánea , Antiinfecciosos Locales/administración & dosificación , Portador Sano/diagnóstico , Portador Sano/tratamiento farmacológico , Portador Sano/microbiología , Estudios de Casos y Controles , Niño , Preescolar , Dermatitis Atópica/diagnóstico , Dermatitis Atópica/tratamiento farmacológico , Farmacorresistencia Bacteriana/genética , Femenino , Voluntarios Sanos , Humanos , Lactante , Recién Nacido , Masculino , Pruebas de Sensibilidad Microbiana , Mutación , Mucosa Nasal/microbiología , Factor G de Elongación Peptídica/genética , Factor G de Elongación Peptídica/aislamiento & purificación , Índice de Severidad de la Enfermedad , Piel/microbiología , Infecciones Cutáneas Estafilocócicas/diagnóstico , Infecciones Cutáneas Estafilocócicas/tratamiento farmacológico , Staphylococcus aureus/aislamiento & purificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA